Clinical Trials in Genoa, Genoa
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
Neuroblastoma
Y-mAbs Therapeutics122 enrolled26 locationsNCT03363373
Recruiting
Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
Alzheimer DiseaseParkinson DiseaseFTD+3 more
Ospedale Policlinico San Martino1,200 enrolled1 locationNCT07235111